IT201800007580A1 - Composti 1,3,8-triazaspiro e loro uso come medicamenti - Google Patents

Composti 1,3,8-triazaspiro e loro uso come medicamenti

Info

Publication number
IT201800007580A1
IT201800007580A1 IT102018000007580A IT201800007580A IT201800007580A1 IT 201800007580 A1 IT201800007580 A1 IT 201800007580A1 IT 102018000007580 A IT102018000007580 A IT 102018000007580A IT 201800007580 A IT201800007580 A IT 201800007580A IT 201800007580 A1 IT201800007580 A1 IT 201800007580A1
Authority
IT
Italy
Prior art keywords
medicaments
triazaspiro compounds
triazaspiro
compounds
Prior art date
Application number
IT102018000007580A
Other languages
English (en)
Inventor
Paolo Pinton
Roberto Ferrari
Carlotta Giorgi
Claudio Trapella
Delia Preti
Giampaolo Morciano
Original Assignee
Maria Cecilia Hospital Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Cecilia Hospital Spa filed Critical Maria Cecilia Hospital Spa
Priority to IT102018000007580A priority Critical patent/IT201800007580A1/it
Priority to DK19761959.6T priority patent/DK3829579T3/da
Priority to PCT/IB2019/055962 priority patent/WO2020021378A1/en
Priority to EP19761959.6A priority patent/EP3829579B1/en
Priority to ES19761959T priority patent/ES2962134T3/es
Priority to PT197619596T priority patent/PT3829579T/pt
Publication of IT201800007580A1 publication Critical patent/IT201800007580A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT102018000007580A 2018-07-27 2018-07-27 Composti 1,3,8-triazaspiro e loro uso come medicamenti IT201800007580A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT102018000007580A IT201800007580A1 (it) 2018-07-27 2018-07-27 Composti 1,3,8-triazaspiro e loro uso come medicamenti
DK19761959.6T DK3829579T3 (da) 2018-07-27 2019-07-12 1,3,8-triazaspiro-forbindelser og anvendelse deraf som lægemidler til behandling af reperfusionsskader
PCT/IB2019/055962 WO2020021378A1 (en) 2018-07-27 2019-07-12 1,3,8-triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury
EP19761959.6A EP3829579B1 (en) 2018-07-27 2019-07-12 1,3,8-triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury
ES19761959T ES2962134T3 (es) 2018-07-27 2019-07-12 Compuestos de 1,3,8-triazaespiro y su uso como medicamentos para el tratamiento de la lesión por reperfusión
PT197619596T PT3829579T (pt) 2018-07-27 2019-07-12 Compostos de 1,3,8-triazaspiro e seu uso como medicamentos para tratamento de lesão de reperfusão

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102018000007580A IT201800007580A1 (it) 2018-07-27 2018-07-27 Composti 1,3,8-triazaspiro e loro uso come medicamenti

Publications (1)

Publication Number Publication Date
IT201800007580A1 true IT201800007580A1 (it) 2020-01-27

Family

ID=63965817

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102018000007580A IT201800007580A1 (it) 2018-07-27 2018-07-27 Composti 1,3,8-triazaspiro e loro uso come medicamenti

Country Status (6)

Country Link
EP (1) EP3829579B1 (it)
DK (1) DK3829579T3 (it)
ES (1) ES2962134T3 (it)
IT (1) IT201800007580A1 (it)
PT (1) PT3829579T (it)
WO (1) WO2020021378A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3191436A1 (en) * 2020-08-11 2022-02-17 Board Of Trustees Of Michigan State University Proteasome enhancers and uses thereof
WO2024201320A1 (en) * 2023-03-31 2024-10-03 Maria Cecilia Hospital S.P.A. New dispiropyrrolidine derivatives as inhibitors of the mptp mitochondrial transition pore in the treatment of ischemic reperfusion injury

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155669A (en) * 1962-06-22 1964-11-03 Res Lab Dr C Janssen N V 2, 4, 8-triaza-spiro (4, 5) dec-2-enes
GB1043141A (en) * 1962-06-22 1966-09-21 Res Lab Dr C Janssen Nv Substituted-4-oxo-1, 3, 8-triazaspiro (4, 5) decanes and their therapeutically active non-toxic acid addition salts and the preparation thereof
WO2002083673A1 (en) * 2001-04-10 2002-10-24 Ortho-Mcneil Pharmaceutical, Inc. 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
EP1254895A1 (en) * 2000-01-20 2002-11-06 Eisai Co., Ltd. Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
US20050131004A1 (en) * 2003-12-12 2005-06-16 Solvay Pharmaceuticals Gmbh. Hydronopol derivatives as agonists on human ORL1 receptors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155669A (en) * 1962-06-22 1964-11-03 Res Lab Dr C Janssen N V 2, 4, 8-triaza-spiro (4, 5) dec-2-enes
GB1043141A (en) * 1962-06-22 1966-09-21 Res Lab Dr C Janssen Nv Substituted-4-oxo-1, 3, 8-triazaspiro (4, 5) decanes and their therapeutically active non-toxic acid addition salts and the preparation thereof
EP1254895A1 (en) * 2000-01-20 2002-11-06 Eisai Co., Ltd. Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
WO2002083673A1 (en) * 2001-04-10 2002-10-24 Ortho-Mcneil Pharmaceutical, Inc. 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
US20050131004A1 (en) * 2003-12-12 2005-06-16 Solvay Pharmaceuticals Gmbh. Hydronopol derivatives as agonists on human ORL1 receptors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GIAMPAOLO MORCIANO ET AL: "Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F 1 /F O -Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction", JOURNAL OF MEDICINAL CHEMISTRY, vol. 61, no. 16, 30 July 2018 (2018-07-30), US, pages 7131 - 7143, XP055571540, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.8b00278 *
GIAMPAOLO MORCIANO ET AL: "Other bricks for the correct construction of the mitochondrial permeability transition pore complex", CELL DEATH & DISEASE, vol. 8, no. 3, 1 March 2017 (2017-03-01), pages e2698 - e2698, XP055571550, DOI: 10.1038/cddis.2017.96 *

Also Published As

Publication number Publication date
EP3829579B1 (en) 2023-08-02
EP3829579A1 (en) 2021-06-09
ES2962134T3 (es) 2024-03-15
PT3829579T (pt) 2023-10-23
DK3829579T3 (da) 2023-10-30
WO2020021378A1 (en) 2020-01-30

Similar Documents

Publication Publication Date Title
JP2016028092A5 (it)
JP2016065085A5 (it)
IL267899A (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors
PT3421038T (pt) Compostos de naftiridina, combinações médicas e sua utilização
SG11201908281VA (en) Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
BR112014025416A2 (pt) AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS.
DK3411008T3 (da) Sammensætninger omfattende aktive solbeskyttelsesmidler med polyhydroxyfulleren
ES2981909T3 (es) Compuestos derivados de pirazolopirazina, composición farmacéutica y utilización de los mismos
ITUB20153829A1 (it) Composti eterociclici trifluoroalchenilici ad attivita nematocida, loro composizioni agronomiche e relativo uso
BR112018005299A2 (pt) 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso
IT201800007580A1 (it) Composti 1,3,8-triazaspiro e loro uso come medicamenti
IL274868A (en) History of imidazopyridine and their use as medicine
IT201600122377A1 (it) Composti di coordinazione e loro formulati, metodi di preparazione ed uso degli stessi come agenti ad azione antiflogistica
IL282142A (en) The history of 4-pyrazine-2-ylmethyl-morpholine and its use as a medicine
ITUB20169937A1 (it) Formulazioni farmaceutiche e loro uso per il trattamento della retinite pigmentosa
ITUB20153759A1 (it) Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo
IT201700028709A1 (it) Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti
IT201600128200A1 (it) Composti ad attivita' fungicida
ITUA20163609A1 (it) "micro-cogeneratore".
DK3153163T3 (da) Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf
ITUB20153499A1 (it) Composti di diidrobenzofurano sostituiti e loro uso come sinergici
BR112016026814A2 (pt) 2,2,2-trifluoroetil-tiadiazinas, intermediário, seu uso e seu processo de preparação, e composição farmacêutica
UA41328S (uk) Стільниця
RU2017102282A (ru) Применение производного бета-морфолинопропиоамидоксима в качестве противодиабетического средства